В статье дается обзор метаанализов, исследующих потребление алкоголя и безалкогольных (кофе, чая, молочных продуктов) напитков в отношении риска рака поджелудочной железы – РПЖ (PubMed, 1995–2019 гг.). Повышенный риск РПЖ был связан с высоким потреблением алкоголя. Повышенный риск употребления алкоголя не объясняется наличием в анамнезе панкреатита, курения табака или диабета. Легкое и умеренное потребление алкоголя может снизить риск РПЖ, вероятно, из-за снижения уровня инсулина, что приводит к снижению риска РПЖ. Взаимосвязь между алкоголем и РПЖ была сильнее у мужчин, чем у женщин. Некоторые метаанализы показали, что небольшое количество кофе может снизить риск РПЖ, а большое количество – повысить риск РПЖ. Другие метаанализы не подтвердили какую-либо связь между риском РПЖ и потреблением кофе или чая. Один метаанализ показал прямую связь риска РПЖ с потреблением молочных продуктов, но большинство исследований не выявило такой связи. Считается, что питание связано с риском РПЖ, но степень риска из-за структуры потребления напитков (доза, длительность, образцы алкоголя, кофе, чая, молочных продуктов) до сих пор не ясна.
This article provides an overview of the metaanalyzes (PubMed, 1995–2019) of alcohol and non-alcoholic (coffee, tea, dairy products) beverage consumption in relation to risk of pancreatic cancer – PC (PubMed, 1995–2019). Increased the PC risk was associated with high alcohol intake. The increased risk for heavy drinking did not explained by residual confounding by history of pancreatitis or tobacco smoking or diabetes. Light-moderate alcohol intake may reduced the PC risk, probably due to the fasting insulin levels decrement, which leads to the diminished the РС risk. The association between alcohol and the PC was stronger in men than in women. Some metaanalyzes demonstrated that a small amount of coffee may reduce PC risk, and a large amount – to increase PC risk. Another meta-analyzes have not confirmed any association between the PC risk and coffee or tea consumption. One meta-analysis revealed a direct association of the PC risk with the dairy products consumption, but most research showed no such connection. Nutrition is considered to be associated with the PC risk, but the degree of risk due to structure of beverages consumption (dose, duration, alcohol, coffee, tea, dairy products pattern) is still not clear.
1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. DOI:10.1002/ijc.29210
2. Григорьева И.Н., Ефимова О.В., Суворова Т.С., Тов Н.Л. Панкреатит, рак поджелудочной железы и ожирение: гипотезы и факты. Экспериментальная и клиническая гастроэнтерология. 2014;9:4-10 [Grigor’eva IN, Efimova OV, Suvorova TS, Tov NL. Pancreatitis, pancreatic cancer and obesity: hypothesis and facts. Eksperimental'naia i klinicheskaia gastroenterologiia. 2014;9:4-10 (in Russian)].
3. Eibl G, Cruz-Monserrate Z, Korc M, et al. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. J Acad Nutr Diet. 2018;118(4):555-67. DOI:10.1016/j.jand.2017.07.005
4. Романова Т.И., Григорьева И.Н., Ефимова О.В. Рак поджелудочной железы. Некоторые молекулярные и генетические механизмы онкогенеза как мишень для терапии. Экспериментальная и клиническая гастроэнтерология. 2017;2:103-109 [Romanova TI, Grigor’eva IN, Efimova OV. Cancer of the pancreas. Some of the molecular and genetic mechanisms of carcinogenesis as a target for therapy. Eksperimental'naia i klinicheskaia gastroenterologiia. 2017;2:103-9 (in Russian)].
5. Meadows GG, Zhang H. Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival. Alcohol Res. 2015; 37(2):311-22.
6. Cuomo R, Andreozzi P, Zito FP. Alcoholic beverages and carbonated soft drinks: consumption and gastrointestinal cancer risks. Cancer Treat Res. 2014;159:97-120.
DOI:10.1007/978-3-642-38007-5_7
7. Duell EJ. Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog. 2012;51(1):40-52. DOI:10.1002/mc.20786
8. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;7(8):599-612. DOI:10.1038/nrc2191
9. Hamid A, Wani NA, Kaur J. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption – association with epigenome stability and cancer development. FEBS J. 2009;276(8):2175-91. DOI:10.1111/j.1742-4658.2009.06959.x
10. Huang X, Li X, Ma Q, et al. Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKK. Int J Mol Med. 2015;35(3):653-63. DOI:10.3892/ijmm.2014.2055
11. Irving HM, Samokhvalov AV, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009;10(4):387-92.
12. Valean S, Chira R, Dumitrascu D. Epidemiological trends in digestive cancers in Romania, 1955-2012, compared to alcohol consumption. Correlation or coincidence? Clujul Med. 2018;91(4):376-86. DOI:10.15386/cjmed-1067
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. DOI:10.1136/bmj.327.7414.557
14. Wang YT, Gou YW, Jin WW, et al. Association between alcohol intake and the risk of pancreatic cancer: a dose-response meta-analysis of cohort studies. BMC Cancer. 2016;16:212. DOI:10.1186/s12885-016-2241-1
15. Li Y, Yang H, Cao J. Association between alcohol consumption and cancers in the Chinese population – a systematic review and meta-analysis. PLoS One. 2011;6(4):e18776. DOI:10.1371/journal.pone.0018776
16. Pang Y, Holmes MV, Guo Y, et al. Smoking, alcohol, and diet in relation to risk of pancreatic cancer in China: a prospective study of 0.5 million people. Cancer Med. 2018;7(1):229-39. DOI:10.1002/cam4.1261
17. Massoneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44(1):186-98. DOI:10.1093/ije/dyu240
18. Michaud DS, Giovannucci E, Willett WC, et al. Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev. 2001;10(5):429-37.
19. Haugvik SP, Hedenström P, Korsæth E, et al. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Neuroendocrinology. 2015;101(2):133-42. DOI:10.1159/000375164
20. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer. 2001;85(11):1700-05. DOI:10.1054/bjoc.2001.2140
21. Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br J Cancer. 2015;112(3):580-93. DOI:10.1038/bjc.2014.579
22. Lazarus R, Sparrow D, Weiss ST. Alcohol intake and insulin levels: The Normative Aging Study. Am J Epidemiol. 1997;145:909-16. DOI:10.1093/oxfordjournals.aje.a009050
23. Gupta S, Wang F, Holly EA, Bracci PM. Risk of pancreatic cancer by alcohol dose, duration, and pattern of consumption, including binge drinking: a population-based study. Cancer Causes Control. 2010;21(7):1047-59. DOI:10.1007/s10552-010-9533-6
24. Tramacere I, Scotti L, Jenab M, et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer. 2010;126(6):1474-86. DOI:10.1002/ijc.24936
25. Welsch T, Kleeff J, Seitz HK, et al. Update on pancreatic cancer and alcohol-associated risk. J Gastroenterol Hepatol. 2006;21(3):S69-75.
26. Genkinger JM, Spiegelman D, Anderson KE, et al. Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev. 2009;18(3):765-76. DOI:10.1158/1055-9965.EPI-08-0880
27. Pourhoseingholi MA, Ashtari S, Hajizadeh N, et al. Systematic review of pancreatic cancer epidemiology in Asia-Pacific Region: major patterns in GLOBOCAN 2012. Gastroenterol Hepatol Bed Bench. 2017;10(4):245-257.
28. Ratna A, Mandrekar P. Alcohol and Cancer: Mechanisms and Therapies. Biomolecules. 2017;7(3):E61. DOI:10.3390/biom7030061
29. Dong J, Zou J, Yu XF. Coffee drinking and pancreatic cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2011;17(9):1204-10. DOI:10.3748/wjg.v17.i9.1204
30. Grigorieva IN. Pancreatic cancer risk factors: a summary review of meta-analytical and prospective cohort studies. Coffee and tea consumption. Экспериментальная и клиническая гастроэнтерология. 2018;3:93-96.
31. Nie K, Xing Z, Huang W, et al. Coffee intake and risk of pancreatic cancer: an updated meta-analysis of prospective studies. Minerva Med. 2016;107(4):270-8.
32. Ran HQ, Wang JZ, Sun CQ. Coffee Consumption and Pancreatic Cancer Risk: An Update Meta-analysis of Cohort Studies. Pak J Med Sci. 2016;32(1):253-9. DOI:10.12669/pjms.321.8761
33. Nishi M, Ohba S, Hirata K, Miyake H. Dose-response Relationship Between Coffee and the Risk of Pancreas Cancer. Jpn J Clin Oncol. 1996;26(1):42-8. DOI:10.1093/oxfordjournals.jjco.a023177
34. Bidel S, Hu G, Jousilahti P, et al. Coffee consumption and risk of gastric and pancreatic cancer – a prospective cohort study. Int J Cancer. 2013;132(7):1651-9. DOI:10.1002/ijc.27773
35. Guertin KA, Freedman ND, Loftfield E, et al. A prospective study of coffee intake and pancreatic cancer: results from the NIH-AARP Diet and Health Study. Br J Cancer. 2015;113(7):1081-85. DOI:10.1038/bjc.2015.235
36. Zhou CD, Kuan AS, Reeves GK, et al. Coffee and pancreatic cancer risk among never-smokers in the UK prospective Million Women Study. Int J Cancer. 2019;145(6):1484-92. DOI:10.1002/ijc.31994
37. Bhoo-Pathy N, Uiterwaal CS, Dik VK, et al. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study. Clin Gastroenterol Hepatol. 2013;11(11):1486-92. DOI:10.1016/j.cgh.2013.05.029
38. Turati F, Galeone C, Edefonti V, et al. A meta-analysis of coffee consumption and pancreatic cancer. Ann Oncol. 2012;23(2):311-8. DOI:10.1093/annonc/mdr331
39. Sanikini H, Dik VK, Siersema PD, et al. Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: results from the EPIC cohort study. Int J Cancer. 2015;136(6):E720-30. DOI:10.1002/ijc.29223
40. Berretta M, Micek A, Lafranconi A, et al. Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies. Oncotarget. 2018;9(29):20807-815. DOI:10.18632/oncotarget.24829
41. Wang A, Wang S, Zhu C, et al. Coffee and cancer risk: A meta-analysis of prospective observational studies. Sci Rep. 2016;6:33711. DOI:10.1038/srep33711
42. Gullo L, Pezzilli R, Morselli-Labate AM. Coffee and cancer of the pancreas: an Italian multicenter study. Pancreas. 1995;11(3):223-9.
DOI:10.1097/00006676-199510000-00002
43. Li TD, Yang HW, Wang P, et al. Coffee consumption and risk of pancreatic cancer: a systematic review and dose-response meta-analysis. Int J Food Sci Nutr. 2019;70(5):519-21. DOI:10.1080/09637486.2018.1551337
44. Nilsson LM, Johansson I, Lenner P, et al. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control. 2010;21(10):1533-44. DOI:10.1007/s10552-010-9582-x
45. Lukic M, Nilsson LM, Skeie G, et al. Coffee consumption and risk of rare cancers in Scandinavian countries. Eur J Epidemiol. 2018;33(3):287-302.
DOI:10.1007/s10654-018-0369-9
46. Poole R, Kennedy OJ, Roderick P, et al. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024. DOI:10.1136/bmj.j5024
47. Takada M, Nakamura Y, Koizumi T, et al. Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas. 2002;25:45-8. DOI:10.1097/00006676-200207000-00012
48. Zheng JS, Yang J, Fu YQ, et al. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutr Cancer. 2013;65(1):1-16. DOI:10.1080/01635581.2013.741762
49. Kang H, Rha SY, Oh KW, Nam CM. Green tea consumption and stomach cancer risk: a meta-analysis. Epidemiol Health. 2010;32:e2010001. DOI:10.4178/epih/e2010001
50. Huang YQ, Lu X, Min H, et al. Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations. Nutrition. 2016;32(1):3-8. DOI:10.1016/j.nut.2015.05.021
51. Tang J, Zheng JS, Fang L, et al. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr. 2015;114(5):673-83. DOI:10.1017/S0007114515002329
52. Zhang YF, Xu Q, Lu J, et al. Tea consumption and the incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Eur J Cancer Prev. 2015;24(4):353-62. DOI:10.1097/CEJ.0000000000000094
53. Zeng JL, Li ZH, Wang ZC, Zhang HL. Green tea consumption and risk of pancreatic cancer: a meta-analysis. Nutrients. 2014;6(11):4640-50. DOI:10.3390/nu6114640
54. Chang B, Sang L, Wang Y, et al. Consumption of tea and risk for pancreatic cancer: a meta-analysis of published epidemiological studies. Nutr Cancer. 2014;66(7):1109-23.
DOI:10.1080/01635581.2014.951730
55. Chen K, Zhang Q, Peng M, et al. Relationship between tea consumption and pancreatic cancer risk: a meta-analysis based on prospective cohort studies and case-control studies. Eur J Cancer Prev. 2014;23(5):353-60. DOI:10.1097/CEJ.0000000000000033
56. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009;3. DOI:10.1002/14651858.CD005004
57. Lin Y, Tamakoshi A, Kikuchi S, et al. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer. 2004;110:584-8. DOI:10.1002/ijc.20147
58. Thiébaut AC, Jiao L, Silverman DT, et al. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst. 2009;101(14):1001-111. DOI:10.1093/jnci/djp168
59. Genkinger JM, Wang M, Li R, et al. Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Ann Oncol. 2014; 25(6):1106-15. DOI:10.1093/annonc/mdu019
60. Lu PY, Shu L, Shen SS, et al. Dietary Patterns and Pancreatic Cancer Risk: A Meta-Analysis. Nutrients. 2017;9(1):38. DOI:10.3390/nu9010038
________________________________________________
1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. DOI:10.1002/ijc.29210
2. Grigor’eva IN, Efimova OV, Suvorova TS, Tov NL. Pancreatitis, pancreatic cancer and obesity: hypothesis and facts. Eksperimental'naia i klinicheskaia gastroenterologiia. 2014;9:4-10 (in Russian).
3. Eibl G, Cruz-Monserrate Z, Korc M, et al. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. J Acad Nutr Diet. 2018;118(4):555-67. DOI:10.1016/j.jand.2017.07.005
4. Romanova TI, Grigor’eva IN, Efimova OV. Cancer of the pancreas. Some of the molecular and genetic mechanisms of carcinogenesis as a target for therapy. Eksperimental'naia i klinicheskaia gastroenterologiia. 2017;2:103-9 (in Russian).
5. Meadows GG, Zhang H. Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival. Alcohol Res. 2015; 37(2):311-22.
6. Cuomo R, Andreozzi P, Zito FP. Alcoholic beverages and carbonated soft drinks: consumption and gastrointestinal cancer risks. Cancer Treat Res. 2014;159:97-120.
DOI:10.1007/978-3-642-38007-5_7
7. Duell EJ. Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog. 2012;51(1):40-52. DOI:10.1002/mc.20786
8. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;7(8):599-612. DOI:10.1038/nrc2191
9. Hamid A, Wani NA, Kaur J. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption – association with epigenome stability and cancer development. FEBS J. 2009;276(8):2175-91. DOI:10.1111/j.1742-4658.2009.06959.x
10. Huang X, Li X, Ma Q, et al. Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKK. Int J Mol Med. 2015;35(3):653-63. DOI:10.3892/ijmm.2014.2055
11. Irving HM, Samokhvalov AV, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009;10(4):387-92.
12. Valean S, Chira R, Dumitrascu D. Epidemiological trends in digestive cancers in Romania, 1955-2012, compared to alcohol consumption. Correlation or coincidence? Clujul Med. 2018;91(4):376-86. DOI:10.15386/cjmed-1067
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. DOI:10.1136/bmj.327.7414.557
14. Wang YT, Gou YW, Jin WW, et al. Association between alcohol intake and the risk of pancreatic cancer: a dose-response meta-analysis of cohort studies. BMC Cancer. 2016;16:212. DOI:10.1186/s12885-016-2241-1
15. Li Y, Yang H, Cao J. Association between alcohol consumption and cancers in the Chinese population – a systematic review and meta-analysis. PLoS One. 2011;6(4):e18776. DOI:10.1371/journal.pone.0018776
16. Pang Y, Holmes MV, Guo Y, et al. Smoking, alcohol, and diet in relation to risk of pancreatic cancer in China: a prospective study of 0.5 million people. Cancer Med. 2018;7(1):229-39. DOI:10.1002/cam4.1261
17. Massoneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44(1):186-98. DOI:10.1093/ije/dyu240
18. Michaud DS, Giovannucci E, Willett WC, et al. Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev. 2001;10(5):429-37.
19. Haugvik SP, Hedenström P, Korsæth E, et al. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Neuroendocrinology. 2015;101(2):133-42. DOI:10.1159/000375164
20. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer. 2001;85(11):1700-05. DOI:10.1054/bjoc.2001.2140
21. Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br J Cancer. 2015;112(3):580-93. DOI:10.1038/bjc.2014.579
22. Lazarus R, Sparrow D, Weiss ST. Alcohol intake and insulin levels: The Normative Aging Study. Am J Epidemiol. 1997;145:909-16. DOI:10.1093/oxfordjournals.aje.a009050
23. Gupta S, Wang F, Holly EA, Bracci PM. Risk of pancreatic cancer by alcohol dose, duration, and pattern of consumption, including binge drinking: a population-based study. Cancer Causes Control. 2010;21(7):1047-59. DOI:10.1007/s10552-010-9533-6
24. Tramacere I, Scotti L, Jenab M, et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer. 2010;126(6):1474-86. DOI:10.1002/ijc.24936
25. Welsch T, Kleeff J, Seitz HK, et al. Update on pancreatic cancer and alcohol-associated risk. J Gastroenterol Hepatol. 2006;21(3):S69-75.
26. Genkinger JM, Spiegelman D, Anderson KE, et al. Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev. 2009;18(3):765-76. DOI:10.1158/1055-9965.EPI-08-0880
27. Pourhoseingholi MA, Ashtari S, Hajizadeh N, et al. Systematic review of pancreatic cancer epidemiology in Asia-Pacific Region: major patterns in GLOBOCAN 2012. Gastroenterol Hepatol Bed Bench. 2017;10(4):245-257.
28. Ratna A, Mandrekar P. Alcohol and Cancer: Mechanisms and Therapies. Biomolecules. 2017;7(3):E61. DOI:10.3390/biom7030061
29. Dong J, Zou J, Yu XF. Coffee drinking and pancreatic cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2011;17(9):1204-10. DOI:10.3748/wjg.v17.i9.1204
30. Grigorieva IN. Pancreatic cancer risk factors: a summary review of meta-analytical and prospective cohort studies. Coffee and tea consumption. Экспериментальная и клиническая гастроэнтерология. 2018;3:93-96.
31. Nie K, Xing Z, Huang W, et al. Coffee intake and risk of pancreatic cancer: an updated meta-analysis of prospective studies. Minerva Med. 2016;107(4):270-8.
32. Ran HQ, Wang JZ, Sun CQ. Coffee Consumption and Pancreatic Cancer Risk: An Update Meta-analysis of Cohort Studies. Pak J Med Sci. 2016;32(1):253-9. DOI:10.12669/pjms.321.8761
33. Nishi M, Ohba S, Hirata K, Miyake H. Dose-response Relationship Between Coffee and the Risk of Pancreas Cancer. Jpn J Clin Oncol. 1996;26(1):42-8. DOI:10.1093/oxfordjournals.jjco.a023177
34. Bidel S, Hu G, Jousilahti P, et al. Coffee consumption and risk of gastric and pancreatic cancer – a prospective cohort study. Int J Cancer. 2013;132(7):1651-9. DOI:10.1002/ijc.27773
35. Guertin KA, Freedman ND, Loftfield E, et al. A prospective study of coffee intake and pancreatic cancer: results from the NIH-AARP Diet and Health Study. Br J Cancer. 2015;113(7):1081-85. DOI:10.1038/bjc.2015.235
36. Zhou CD, Kuan AS, Reeves GK, et al. Coffee and pancreatic cancer risk among never-smokers in the UK prospective Million Women Study. Int J Cancer. 2019;145(6):1484-92. DOI:10.1002/ijc.31994
37. Bhoo-Pathy N, Uiterwaal CS, Dik VK, et al. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study. Clin Gastroenterol Hepatol. 2013;11(11):1486-92. DOI:10.1016/j.cgh.2013.05.029
38. Turati F, Galeone C, Edefonti V, et al. A meta-analysis of coffee consumption and pancreatic cancer. Ann Oncol. 2012;23(2):311-8. DOI:10.1093/annonc/mdr331
39. Sanikini H, Dik VK, Siersema PD, et al. Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: results from the EPIC cohort study. Int J Cancer. 2015;136(6):E720-30. DOI:10.1002/ijc.29223
40. Berretta M, Micek A, Lafranconi A, et al. Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies. Oncotarget. 2018;9(29):20807-815. DOI:10.18632/oncotarget.24829
41. Wang A, Wang S, Zhu C, et al. Coffee and cancer risk: A meta-analysis of prospective observational studies. Sci Rep. 2016;6:33711. DOI:10.1038/srep33711
42. Gullo L, Pezzilli R, Morselli-Labate AM. Coffee and cancer of the pancreas: an Italian multicenter study. Pancreas. 1995;11(3):223-9.
DOI:10.1097/00006676-199510000-00002
43. Li TD, Yang HW, Wang P, et al. Coffee consumption and risk of pancreatic cancer: a systematic review and dose-response meta-analysis. Int J Food Sci Nutr. 2019;70(5):519-21. DOI:10.1080/09637486.2018.1551337
44. Nilsson LM, Johansson I, Lenner P, et al. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control. 2010;21(10):1533-44. DOI:10.1007/s10552-010-9582-x
45. Lukic M, Nilsson LM, Skeie G, et al. Coffee consumption and risk of rare cancers in Scandinavian countries. Eur J Epidemiol. 2018;33(3):287-302.
DOI:10.1007/s10654-018-0369-9
46. Poole R, Kennedy OJ, Roderick P, et al. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024. DOI:10.1136/bmj.j5024
47. Takada M, Nakamura Y, Koizumi T, et al. Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas. 2002;25:45-8. DOI:10.1097/00006676-200207000-00012
48. Zheng JS, Yang J, Fu YQ, et al. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutr Cancer. 2013;65(1):1-16. DOI:10.1080/01635581.2013.741762
49. Kang H, Rha SY, Oh KW, Nam CM. Green tea consumption and stomach cancer risk: a meta-analysis. Epidemiol Health. 2010;32:e2010001. DOI:10.4178/epih/e2010001
50. Huang YQ, Lu X, Min H, et al. Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations. Nutrition. 2016;32(1):3-8. DOI:10.1016/j.nut.2015.05.021
51. Tang J, Zheng JS, Fang L, et al. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr. 2015;114(5):673-83. DOI:10.1017/S0007114515002329
52. Zhang YF, Xu Q, Lu J, et al. Tea consumption and the incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Eur J Cancer Prev. 2015;24(4):353-62. DOI:10.1097/CEJ.0000000000000094
53. Zeng JL, Li ZH, Wang ZC, Zhang HL. Green tea consumption and risk of pancreatic cancer: a meta-analysis. Nutrients. 2014;6(11):4640-50. DOI:10.3390/nu6114640
54. Chang B, Sang L, Wang Y, et al. Consumption of tea and risk for pancreatic cancer: a meta-analysis of published epidemiological studies. Nutr Cancer. 2014;66(7):1109-23.
DOI:10.1080/01635581.2014.951730
55. Chen K, Zhang Q, Peng M, et al. Relationship between tea consumption and pancreatic cancer risk: a meta-analysis based on prospective cohort studies and case-control studies. Eur J Cancer Prev. 2014;23(5):353-60. DOI:10.1097/CEJ.0000000000000033
56. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009;3. DOI:10.1002/14651858.CD005004
57. Lin Y, Tamakoshi A, Kikuchi S, et al. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer. 2004;110:584-8. DOI:10.1002/ijc.20147
58. Thiébaut AC, Jiao L, Silverman DT, et al. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst. 2009;101(14):1001-111. DOI:10.1093/jnci/djp168
59. Genkinger JM, Wang M, Li R, et al. Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Ann Oncol. 2014; 25(6):1106-15. DOI:10.1093/annonc/mdu019
60. Lu PY, Shu L, Shen SS, et al. Dietary Patterns and Pancreatic Cancer Risk: A Meta-Analysis. Nutrients. 2017;9(1):38. DOI:10.3390/nu9010038
Авторы
И.Н. Григорьева*
Научно-исследовательский институт терапии и профилактической медицины – филиал ФГБНУ «Федеральный исследовательский центр “Институт цитологии и генетики”» СО РАН, Новосибирск, Россия
*igrigorieva@ngs.ru
________________________________________________
Irina N. Grigor’eva*
Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics, Novosibirsk, Russia
*igrigorieva@ngs.ru